Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Clinical Lung Cancer|January 16, 2026
Patient-Relevant Outcomes From the Phase III MARIPOSA-2 Trial: Amivantamab-Chemotherapy Versus Chemotherapy in EGFR-Mutant Advanced Non-Small-Cell Lung Cancer Following Disease Progression on OsimertinibPascale Tomasini, Oscar Juan-Vidal, Raffaele Califano, et al.
Translational Lung Cancer Research|December 3, 2021
Are there differences by sex in lung cancer characteristics at diagnosis? -a nationwide studyAlberto Ruano-Ravina, Mariano Provencio, Virginia Calvo de Juan, et al.
Cancer Treatment and Research Communications|March 28, 2025
Efficacy and safety of lorlatinib in patients with ALK- and ROS1-rearranged metastatic non-small cell lung cancer treated within the compassionate use program in SpainAntonio Calles, Mirian Alonso, Paloma Martín-Martorell, et al.
European Journal of Cancer (Oxford, England : 1990)|April 8, 2021
Analysis of circulating tumour DNA to identify patients with epidermal growth factor receptor-positive non-small cell lung cancer who might benefit from sequential tyrosine kinase inhibitor treatmentMariano Provencio, Roberto Serna-Blasco, Fabio Franco, et al.
Lung Cancer (Amsterdam, Netherlands)|August 28, 2023
Immunogenicity of COVID-19 vaccines in lung cancer patientsMariano Provencio, Anna Estival, Fernando Franco, et al.
Nature Communications|December 23, 2025
Induction chemo-immunotherapy followed by chemo-radiotherapy and immunotherapy maintenance in stage III NSCLC (APOLO): a phase 2 trialMariano Provencio, Begoña Campos, María Guirado, et al.
Molecular Oncology|October 27, 2020
Comprehensive cross-platform comparison of methods for non-invasive EGFR mutation testing: results of the RING observational trialAtocha Romero, Eloisa Jantus-Lewintre, Beatriz García-Peláez, et al.
British Journal of Cancer|May 18, 2016
A nomogram for predicting complications in patients with solid tumours and seemingly stable febrile neutropeniaPaula Jiménez Fonseca, Alberto Carmona-Bayonas, Ignacio Matos García, et al.
JTO Clinical and Research Reports|June 8, 2026
Multidisciplinary Approach to Sexual Dysfunction in Persons With Lung Cancer-Spanish Lung Cancer Group Expert Consensus StatementAylen Vanessa Ospina-Serrano, Constanza Maximiano-Alonso, Pau Guillén-Sentís, et al.
European Journal of Cancer (Oxford, England : 1990)|November 9, 2020
High risk of thrombosis in patients with advanced lung cancer harboring rearrangements in ROS1Nerea Muñoz-Unceta, Jon Zugazagoitia, Arancha Manzano, et al.
Pageof 10